Municipal Employees Retirement System of Michigan lessened its holdings in Becton, Dickinson and Company (NYSE:BDX) by 20.9% during the 3rd quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 5,877 shares of the medical instruments supplier’s stock after selling 1,550 shares during the period. Municipal Employees Retirement System of Michigan’s holdings in Becton, Dickinson and were worth $1,152,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Almanack Investment Partners LLC. bought a new stake in Becton, Dickinson and during the 1st quarter worth approximately $105,000. Mitsubishi UFJ Securities Holdings Co. Ltd. raised its stake in Becton, Dickinson and by 55.8% during the 2nd quarter. Mitsubishi UFJ Securities Holdings Co. Ltd. now owns 670 shares of the medical instruments supplier’s stock worth $131,000 after acquiring an additional 240 shares during the period. Parkside Financial Bank & Trust raised its stake in Becton, Dickinson and by 8.1% during the 2nd quarter. Parkside Financial Bank & Trust now owns 684 shares of the medical instruments supplier’s stock worth $133,000 after acquiring an additional 51 shares during the period. Harfst & Associates Inc. raised its stake in Becton, Dickinson and by 46.4% during the 2nd quarter. Harfst & Associates Inc. now owns 697 shares of the medical instruments supplier’s stock worth $135,000 after acquiring an additional 221 shares during the period. Finally, Financial Architects Inc raised its stake in Becton, Dickinson and by 8.0% during the 2nd quarter. Financial Architects Inc now owns 731 shares of the medical instruments supplier’s stock worth $142,000 after acquiring an additional 54 shares during the period. Institutional investors own 87.91% of the company’s stock.

In other news, insider Stephen Sichak sold 11,787 shares of the business’s stock in a transaction on Friday, September 8th. The shares were sold at an average price of $200.46, for a total transaction of $2,362,822.02. Following the completion of the sale, the insider now directly owns 14,038 shares of the company’s stock, valued at $2,814,057.48. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Gary M. Cohen sold 15,512 shares of Becton, Dickinson and stock in a transaction dated Monday, September 11th. The shares were sold at an average price of $203.77, for a total value of $3,160,880.24. Following the completion of the sale, the insider now owns 95,781 shares of the company’s stock, valued at $19,517,294.37. The disclosure for this sale can be found here. 1.40% of the stock is currently owned by insiders.

Becton, Dickinson and Company (BDX) opened at $226.83 on Wednesday. The company has a debt-to-equity ratio of 1.48, a quick ratio of 5.01 and a current ratio of 5.56. The company has a market cap of $50,405.64, a price-to-earnings ratio of 23.34, a price-to-earnings-growth ratio of 1.73 and a beta of 1.04. Becton, Dickinson and Company has a one year low of $161.29 and a one year high of $227.50.

Becton, Dickinson and (NYSE:BDX) last issued its earnings results on Thursday, November 2nd. The medical instruments supplier reported $2.40 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $2.37 by $0.03. The firm had revenue of $3.17 billion during the quarter, compared to analyst estimates of $3.14 billion. Becton, Dickinson and had a net margin of 8.52% and a return on equity of 22.51%. The business’s revenue was down 2.0% on a year-over-year basis. During the same period in the previous year, the firm earned $2.12 earnings per share. equities analysts anticipate that Becton, Dickinson and Company will post 10.63 EPS for the current fiscal year.

The business also recently announced a quarterly dividend, which will be paid on Friday, December 29th. Stockholders of record on Friday, December 8th will be paid a dividend of $0.75 per share. This is a positive change from Becton, Dickinson and’s previous quarterly dividend of $0.73. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.32%. The ex-dividend date of this dividend is Thursday, December 7th. Becton, Dickinson and’s payout ratio is currently 62.80%.

ILLEGAL ACTIVITY NOTICE: “Municipal Employees Retirement System of Michigan Sells 1,550 Shares of Becton, Dickinson and Company (BDX)” was first posted by The Cerbat Gem and is the property of of The Cerbat Gem. If you are reading this report on another domain, it was illegally stolen and reposted in violation of U.S. and international trademark & copyright laws. The original version of this report can be read at https://www.thecerbatgem.com/2017/11/22/municipal-employees-retirement-system-of-michigan-sells-1550-shares-of-becton-dickinson-and-company-bdx.html.

A number of equities research analysts have commented on BDX shares. Royal Bank Of Canada restated a “hold” rating and set a $210.00 target price on shares of Becton, Dickinson and in a research note on Wednesday, October 25th. Zacks Investment Research cut shares of Becton, Dickinson and from a “hold” rating to a “sell” rating in a research report on Monday, October 9th. Stifel Nicolaus reiterated a “buy” rating and set a $245.00 price objective on shares of Becton, Dickinson and in a research report on Friday, November 3rd. Morgan Stanley lifted their price objective on shares of Becton, Dickinson and from $205.00 to $245.00 and gave the company an “equal weight” rating in a research report on Friday, November 3rd. Finally, Wells Fargo & Company reiterated a “positive” rating and set a $235.00 price objective (up previously from $225.00) on shares of Becton, Dickinson and in a research report on Tuesday, October 24th. They noted that the move was a valuation call. Four equities research analysts have rated the stock with a hold rating, ten have issued a buy rating and one has issued a strong buy rating to the company’s stock. The company has an average rating of “Buy” and a consensus price target of $217.08.

Becton, Dickinson and Profile

Becton, Dickinson and Company (BD) is a global medical technology company engaged in the development, manufacture and sale of a range of medical supplies, devices, laboratory equipment and diagnostic products. The Company operates through two segments: BD Medical and BD Life Sciences. The BD Medical segment produces an array of medical technologies and devices that are used to help improve healthcare delivery in a range of settings.

Want to see what other hedge funds are holding BDX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Becton, Dickinson and Company (NYSE:BDX).

Institutional Ownership by Quarter for Becton, Dickinson and (NYSE:BDX)

Receive News & Stock Ratings for Becton Dickinson and Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Becton Dickinson and Company and related stocks with our FREE daily email newsletter.